Multiple Sclerosis – Treatment to Reduce Symptoms and Modify course of Disease
Multiple sclerosis is treated with drugs that modify the course of the disease, suppress immunity and relieve symptoms.
Source: medindia.net
Natalizumab News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Natalizumab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Natalizumab Today - Breaking & Trending Today
Patient-Reported Outcomes Reinforce Efficacy of Natalizumab for MS
Researchers gathered data on patient-reported outcomes to support evidence for the continuation of natalizumab, a disease-modifying treatment, in the management of multiple sclerosis (MS) progression.
Source: ajmc.com
Anti-CD20 Therapies Shown to be Effective After Switch From Natalizumab
Following the switch from natalizumab, patients with multiple sclerosis on anti-CD20 therapies like rituximab demonstrated significant reductions in annualized relapse rate.
Source: ajmc.com
FDA Approves Natalizumab Biosimilar, First for Multiple Sclerosis
The FDA has approved the first biosimilar to treat multiple sclerosis, Sandoz's injection treatment natalizumab-sztn (Tyruko).
Source: ajmc.com
Biogen Seeks A Preliminary Injunction In Natalizumab BPCIA Case Against Sandoz - Patent
Biogen seeks a preliminary injunction in its BPCIA case against Sandoz related to Sandoz's proposed biosimilar of TYSABRI (natalizumab). On October 20, 2022, the Court issued a sealed order on the parties' joint...
Source: mondaq.com